Thursday, December 01, 2016 4:31:41 PM
Volume Weighted Average Price
$3.30 .... Dec 01, 2016
$3.45 .... Nov 30, 2016
$3.48 .... Nov 29, 2016
$3.33 .... Nov 28, 2016
$3.29 .... Nov 25, 2016
$3.28 .... Nov 23, 2016
$3.23 .... Nov 22, 2016
$3.20 .... Nov 21, 2016
$3.40 .... Nov 18, 2016
$3.28 .... Nov 17, 2016
$3.11 .... Nov 16, 2016 << Lowest Avg Price in 12 months
$3.18 .... Nov 15, 2016
$3.33 .... Nov 14, 2016
$3.47 .... Nov 11, 2016
$3.53 .... Nov 10, 2016
$3.51 .... Nov 09, 2016
$3.77 .... Nov 08, 2016
$4.01 .... Nov 07, 2016
$4.13 .... Nov 04, 2016
$4.14 .... Nov 03, 2016
$4.22 .... Nov 02, 2016
$4.36 .... Nov 01, 2016
$4.49 .... Oct 31, 2016
$4.48 .... Oct 28, 2016
$4.64 .... Oct 27, 2016
$4.65 .... Oct 26, 2016
$4.83 .... Oct 25, 2016
$4.93 .... Oct 24, 2016
$5.08 .... Oct 21, 2016
$5.10 .... Oct 20, 2016
$5.14 .... Oct 19, 2016
$4.71 .... Oct 18, 2016
$5.19 .... Oct 17, 2016
$5.35 .... Oct 14, 2016
$6.00 .... Oct 13, 2016
$6.62 .... Oct 12, 2016
$6.85 .... Oct 11, 2016
$7.08 .... Oct 10, 2016
$8.00 .... Oct 07, 2016
___________________Reverse Split (1:10)
$0.755 ... Oct 06, 2016
$0.794 ... Oct 05, 2016
$0.799 ... Oct 04, 2016
$0.766 ... Oct 03, 2016
$0.760 ... Sep 30, 2016
$0.767 ... Sep 29, 2016
$0.777 ... Sep 28, 2016
$0.784 ... Sep 27, 2016
$0.794 ... Sep 26, 2016
$0.821 ... Sep 23, 2016
$0.785 ... Sep 22, 2016
$0.763 ... Sep 21, 2016
$0.756 ... Sep 20, 2016
$0.734 ... Sep 19, 2016
$0.714 ... Sep 16, 2016
$0.712 ... Sep 15, 2016
$0.722 ... Sep 14, 2016
$0.704 ... Sep 13, 2016
$0.715 ... Sep 12, 2016
$0.745 ... Sep 09, 2016
$0.687 ... Sep 08, 2016
$0.647 ... Sep 07, 2016
$0.624 ... Sep 06, 2016
$0.626 ... Sep 02, 2016
$0.617 ... Sep 01, 2016
$0.607 ... Aug 31, 2016
$0.604 ... Aug 30, 2016
$0.622 ... Aug 29, 2016
$0.618 ... Aug 26, 2016
$0.584 ... Aug 25, 2016
$0.586 ... Aug 24, 2016
$0.591 ... Aug 23, 2016
$0.590 ... Aug 22, 2016
$0.596 ... Aug 19, 2016
$0.621 ... Aug 18, 2016
$0.622 ... Aug 17, 2016
$0.597 ... Aug 16, 2016
$0.616 ... Aug 15, 2016
$0.654 ... Aug 12, 2016
$0.627 ... Aug 11, 2016
$0.607 ... Aug 10, 2016
$0.598 ... Aug 09, 2016
$0.611 ... Aug 08, 2016
$0.622 ... Aug 05, 2016
$0.616 ... Aug 04, 2016
$0.614 ... Aug 03, 2016
$0.610 ... Aug 02, 2016
$0.616 ... Aug 01, 2016
$0.616 ... Jul 29, 2016
$0.615 ... Jul 28, 2016
$0.618 ... Jul 27, 2016
$0.615 ... Jul 26, 2016
$0.623 ... Jul 25, 2016
$0.637 ... Jul 22, 2016
$0.654 ... Jul 21, 2016
$0.656 ... Jul 20, 2016
$0.637 ... Jul 19, 2016
$0.615 ... Jul 18, 2016
$0.620 ... Jul 15, 2016
$0.625 ... Jul 14, 2016
$0.622 ... Jul 13, 2016
$0.626 ... Jul 12, 2016
$0.632 ... Jul 11, 2016
$0.635 ... Jul 08, 2016
$0.652 ... Jul 07, 2016
$0.640 ... Jul 06, 2016
$0.624 ... Jul 05, 2016
$0.631 ... Jul 01, 2016
$0.640 ... Jun 30, 2016
$0.637 ... Jun 29, 2016
$0.661 ... Jun 28, 2016
$0.628 ... Jun 27, 2016
$0.666 ... Jun 24, 2016
$0.706 ... Jun 23, 2016
$0.709 ... Jun 22, 2016
$0.708 ... Jun 21, 2016
$0.707 ... Jun 20, 2016
$0.744 ... Jun 17, 2016
$0.734 ... Jun 16, 2016
$0.728 ... Jun 15, 2016
$0.734 ... Jun 14, 2016
$0.759 ... Jun 13, 2016
$0.788 ... Jun 10, 2016
$0.768 ... Jun 09, 2016
$0.771 ... Jun 08, 2016
$0.795 ... Jun 07, 2016
Recent SNGX News
- Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results • PR Newswire (US) • 03/15/2024 11:30:00 AM
- Soligenix Announces Formation of Behçet's Disease Medical Advisory Board • PR Newswire (US) • 02/08/2024 12:30:00 PM
- Soligenix to Present at The Microcap Conference • PR Newswire (US) • 01/25/2024 12:30:00 PM
- FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease • PR Newswire (US) • 01/08/2024 12:30:00 PM
- Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis • PR Newswire (US) • 01/04/2024 12:30:00 PM
- Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses • PR Newswire (US) • 01/02/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:05:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/18/2023 05:15:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:10:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:10:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:10:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:10:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:03:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:12:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:11:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:10:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:10:16 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/08/2023 09:05:59 PM
- "HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery • PR Newswire (US) • 12/01/2023 12:30:00 PM
- Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease • PR Newswire (US) • 11/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:26 PM
- Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting • PR Newswire (US) • 11/17/2023 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:00:43 PM
- Soligenix Announces Recent Accomplishments And Third Quarter 2023 Financial Results • PR Newswire (US) • 11/13/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:30 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM